Back

Novel Designer Natriuretic Peptide (ZD100) in Human Resistant-Like Hypertension - A First in Human Study

28 August 2016 (11:18 - 11:36)
Organised by:
Congress Presentation Part of: Resistant hypertension Treatment of hypertension ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Horng Chen

Mayo Clinic, Rochester (United States of America)

4 More presentations in this session

Presentation thumbnail
State of the art in treatment of resistant hypertension.
Professor R. Schmieder (Erlangen, DE)
Slides Video
Presentation thumbnail
The role of adding spironolactone and renal denervation in true resistant hypertension. one-year outcomes of randomized study.
Doctor J. Rosa (Nymburk, CZ)
Abstract Slides Video
Presentation thumbnail
SYMPLICITY HTN-3 screen failure patient cohort analysis
Doctor R. Waksman (Washington, DC, US)
Abstract Slides Video
Presentation thumbnail
Future direction for research in management of resistant hypertension.
Professor A. Pathak (Luxembourg, LU)
Slides Video

Access the full session

Session thumbnail
Resistant hypertension

The Event

Event poster

ESC Congress 2016

28 August 2016 11:18 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources